Thomas Dubensky

Thomas Dubensky

Amministratore Delegato presso
ImmuneSensor Therapeutics, Inc.
68 anni
Health Technology
Commercial Services
Consumer Services

Profilo

Thomas W.
Dubensky
was the founder of Anza Therapeutics, Inc. (2007), holding the title of Chief Scientific Officer in 2010.
Dr. Dubensky is the founder of ImmuneSensor Therapeutics, Inc., serving as President, Chief Executive Officer & Director since 2024.
Former positions include Chief Executive Officer & Director at TempestTx, Inc., Scientific Director at Chiron Corp., Director at HTG Molecular Diagnostics, Inc. (2022-2023), President & Director at Tempest Therapeutics, Inc. (2017-2023), Vice President at Onyx Pharmaceuticals, Inc., Vice President-Research at Cerus Corp.
(2002-2007), Chief Scientific Officer at Aduro BioTech, Inc. (2011-2017), Principal at Chiron Viagene, Inc., and Chief Scientific Officer at Immune Design Corp.
Education includes an undergraduate degree from the University of California, Berkeley and a doctorate from the University of Colorado Health Sciences Center.

Posizioni attive di Thomas Dubensky

SocietàPosizioneInizio
Amministratore Delegato 01/05/2024

Precedenti posizioni note di Thomas Dubensky

SocietàPosizioneFine
TEMPEST THERAPEUTICS, INC. Presidente 15/09/2023
HTG MOLECULAR DIAGNOSTICS, INC. Direttore/Membro del Consiglio 01/08/2023
CHINOOK THERAPEUTICS, INC. Direttore Tecnico/Scientifico/R&S 31/08/2017
CERUS CORPORATION Direttore Tecnico/Scientifico/R&S 16/11/2007
Amministratore Delegato -
Vedi nel dettaglio l'esperienza di Thomas Dubensky

Formazione di Thomas Dubensky

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

49

Relazioni di 1° grado

13

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private13

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Commercial Services

Consumer Services

Consumer Services

Health Technology

Health Technology

Commercial Services

Health Technology

  1. Mercati
  2. Insiders
  3. Thomas Dubensky
-40%: Proroga eccezionale
g
:
:
ENTRA ORA